184. Skaper SD, Facci L, Giusti P. Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol Disord Drug Targets. 2014;13:1654-66.
185. Kanba S, Kato T. [Microglial hypothesis of schizophrenia]. Nihon Shinkei Seishin Yakurigaku Zasshi. 2014;34:11-3.
186. Stertz L, Magalhães PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry. 2013;26:19-26.
187. Singh MM, Kay SR Wheat gluten as a pathogenic factor in schizophrenia.
188. Peleg R, Ben-Zion ZI, Peleg A, Et al. “Bread madness” revisited: screening for specific celiac antibodies among schizophrenia patients. Eur Psychiatry. 2004;19:311-4.
189.Dickerson F, Stallings C, Origoni A,et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episodeschizophrenia. Biol Psychiatry. 2010;68:100-4.
190. Cascella NG, Kryszak D, Bhatti B,et al. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull. 2011;37:94-100.
191.Samaroo D, Dickerson F, Kasarda D, Green P, Briani C, Yolken RH, Alaedini A. Novel immune response to gluten in individuals with Schizophrenia. Schizophr Res. 2010;118:248–255.
192. Jin SZ, Wu N, Xu Q, Zhang X, Ju GZ, Law MH, We IJ. A study of circulating gliadin antibodies in schizophrenia among a Chinese population. Schizophr Bull. 2012;38:514–518.
193. Ludvigsson JF, Osby U, Ekbom A, Montgomery SM. Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study. Scand J Gastroenterol. 2007;42:179-85.
194. Cascella NG, Santora D, Gregory P, Kelly DL, Fasano A, Eaton WW. Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients. Schizophr Bull. 2013;39:867-71.
195-Jansson B, Kristjansson E, Nilsson L. Schizophrenic psychosis disappearing after patient is given gluten-free diet. Lakartidningen. 1984;81:448–449.
196. De Santis A, Addolorato G, Romito A,et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med. 1997;242:421-3.
197. Jackson J, Eaton W, Cascella N,et al. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res. 2012;140:262-3.
198. Sabel’nikova EA, Krums LM, Parfenov AI,et al. Gluten-sensitive celiac disease associated with recurrent aphthous stomatitis andschizophrenia. Ter Arkh. 2013;85:54-6.
199. Vlissides DN, Venulet A, Jenner FA. A double-blind gluten-free/gluten-load controlled trial in a secure ward population. Br J Psychiatry. 1986;148:447-52.
200. Kalaydjian AE, Eaton W, Cascella N, Fasano A.The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006;113:82-90.
201. Niebuhr DW, Li Y, Cowan DN,et al. Association between bovine casein antibody and new onset schizophrenia among US military personnel. Schizophr Res. 2011;128:51-5.
202. Severance EG, Alaedini A, Yang S,et al Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res. 2012;138:48-53.
203. Chen YH, Lee HC, Lin HC. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res. 2009 ;108:191-6.
204. Hällgren R, Venge P, Wistedt B. Elevated serum levels of lactoferrin and eosinophil cationic protein in schizophrenic patients. Br J Psychiatry. 1982;140:55-60.
205. Dickerson F, Stallings C, Origoni A, et al. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord. 2011;13:52-8.
206. Dickerson F, Stallings C, Origoni A,et al. Markers of gluten sensitivity in acute mania: a longitudinal study. Psychiatry Res. 2012;196:68-71.
207. Saleem A, Connor HJ, Regan PO. Adult coeliac disease in Ireland: a case series. Ir J Med Sci. 2012;181:225-9.
208-219- Severance EG, Dupont D, Dickerson FB,et al. Immune activation by casein dietary antigens in bipolar disorder. Bipolar Disord. 2010;12:834-42.
209. Severance EG, Gressitt KL, Yang S, et al. Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 2014;16:230-4.
210. Lin TC, Lee CT, Lai TJ, Et al. Association of asthma and bipolar disorder: a nationwide population-based study in Taiwan. J Affect Disord. 2014;168:30-6.
211. Ciacci C, Iavarone A, Mazzacca G, De Rosa A. Depressive symptoms in adult coeliac disease. Scand J Gastroenterol. 1998;33:247-50.
212. Smith DF, Gerdes LU. Meta-analysis on anxiety and depression in adult celiac disease.Acta Psychiatr Scand. 2012;125:189-93.
213. Karakuła-Juchnowicz H, Szachta P, et al.The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders. Nutr Neurosci. 2014 Sep 30.
214. Niederhofer H. Association of attention-deficit/hyperactivity disorder and celiac disease: a brief report. Prim Care Companion CNS Disord. 2011;13(3). pii: PCC.10br01104.
215. Güngör S, Celiloğlu OS, Ozcan OO, Raif SG, Selimoğlu MA. Frequency of celiac disease in attention-deficit/hyperactivity disorder. J Pediatr Gastroenterol Nutr. 2013;56:211-4.
216. Kanarek RB. Artificial food dyes and attention deficit hyperactivity disorder. Nutr Rev. 2011;69:385-91.
217. 217. McCann D, Barrett A, Cooper A, et al. Food additives and hyperactive behavior in 3-year-old and 8/9-year-old children in the community: A randomized, double-blinded, placebo-controlled trial. Lancet. 2007;370:1560–7.
218. Addolorato G, Capristo E, Ghittoni G, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study.Scand J Gastroenterol. 2001;36:502-6.